All Work

Chris Lange

Key Analyst Sees Nearly 30% Upside in Ironwood

Merrill Lynch brings another company to the forefront that it considers a buy. Ironwood Pharmaceuticals is viewed favorably by the brokerage firm, with nearly 30% upside.

Chris Lange · 11 years ago

Is Newmont Now the Best Big Gold Stock?

Newmont Mining just received a favorable upgrade from none other than Credit Suisse. Also, additional color from Sterne Agee.

Chris Lange · 11 years ago

A Real Heartbreak for Celladon

Celladon announced negative results in clinical trial and shares plunged 80% Monday morning.

Chris Lange · 11 years ago

Short Sellers Become More Wary of Big Biotech

The short interest data are out for the April 15 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.

Chris Lange · 11 years ago

The Other 8 Top Tech Earnings This Week

24/7 Wall St. has put together a preview of some of the larger companies in the tech sector reporting their quarterly results at the end of April.

Chris Lange · 11 years ago

Has AT&T Stock Finally Bottomed?

Included in the summary here are a couple of analysts' calls in relation to AT&T earnings and a summary of details from each call.

Chris Lange · 11 years ago

How Analysts View eBay After Earnings

Analysts are weighing in on the future of eBay and what these earnings mean for its spin-off of PayPal. 24/7 Wall St. has briefly looked at earnings and given summary details for each analyst…

Chris Lange · 11 years ago